Resource use and cost associated with cardiovascular, renal, bone and neuropsychiatric comorbidities in people with HIV in Spain

Study measuring the cost associated with comorbidities in people living with HIV during the 2024–2034 period, based on national prevalence data and different assumptions regarding ART (antiretroviral therapy) regimens.
Usability and validity of a mobile health app for people living with HIV to prepare for the next physician’s visit

Evaluation of the mHealth app PTC as an alternative to PROs in people living with HIV showed high usability, satisfaction, and usefulness. PTC correlated well with validated PROs and enables assessment of quality of life, symptoms, and emotional well-being with lower burden.
Is Less Truly More? Reassessing Safety Analysis for HIV Patients Switching from Triple to Double Regimens with Integrase Inhibitors: A Systematic Review and Meta-Analysis

This study aimed to determine if there are benefits of treatment simplification in terms of safety and tolerability to help in the decision-making in routine clinical practice and to provide the best therapeutic option for patients. This research outlines that there is still insufficient information to claim that simplifying from 3DR or 4DR to 2DR […]
Validación de una herramienta digital para la recogida de resultados reportados por los pacientes (PROs) previamente a la consulta médica en personas que viven con el VIH: “Prepara tu consulta”

“Prepara tu consulta” is a mHealth app developed to collect patient-reported outcomes (PRO) from people living with HIV (PLWH) before the physician’s visit. The validity of the app as a tool to report health-related quality of life (HRQOL) in PLWH has not been studied yet. We aimed to analyse the correlation between the app questionnaire […]
Healthcare resource utilization and related cost of non-HIV comorbidities management in people living with HIV in a Spanish cohort from 2007-2016

Retrospective cohort study to assess resource use and costs associated with non-HIV comorbidities between 2007 and 2016.
Resource utilization associated with the management of potential interactions between direct-acting antivirals for chronic hepatitis C treatment and cardiovascular and central nervous system drugs

Evaluation of the additional actions and resource utilization required for the management of potential drug-drug interactions in HCV patients showing cardiovascular and central nervous system comorbidities, treated with sofosbuvir/velpatasvir compared to glecaprevir/ pibrentasvir in routine clinical practice in Spain.
Healthcare resource use and associated costs in a cohort of hospitalized COVID-19 patients in Spain: A retrospective analysis from the first to the third pandemic wave. EPICOV study

We conducted a retrospective observational study to describe healthcare resource use and costs per hospitalized coronavirus disease-2019 (COVID-19) patient during the three main outbreak waves.
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain

A discrete choice experiment to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain.
Preferencias sociales en la vacunación frente a la enfermedad meningocócica invasiva causada por neisseria meningitidis del serogrupo b en España

Parents’ and paediatricians’ preferences for the characteristics of the vaccines against MenB.
Uso de recursos y costes asociados a las comorbilidades cardiovascular, renal, ósea y neuropsiquiátrica en pacientes con infección por VIH en España

Economic impact based on a scenario analysis to estimate the cost of cardiovascular, renal, bone and neuropsychiatric comorbidities in people living with human immunodeficiency virus in a current scenario versus alternative scenarios that simulate an increase in comorbidities due to toxicity that could be associated with certain treatments, over a 10-year time horizon and from […]